ロード中...
Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Therapeutic strategies that augment antiviral immunity and reduce the viral reservoir are critical to achieving durable remission of HIV. The coinhibitory receptor programmed death-1 (PD-1) regulates CD8(+) T cell dysfunction during chronic HIV and SIV infections. We previously demonstrated that in...
保存先:
| 出版年: | JCI Insight |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237231/ https://ncbi.nlm.nih.gov/pubmed/30232277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122940 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|